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in the ocular lens and is involved in cataract. As the age-related form affects about half of the popu-
lation world-wide, understanding relevant pathomechanisms is a prerequisite for exploring non-invasive
treatments. We screened the coding exons of the gene SLC16A12 in 877 patients from five cohorts,
including Caucasian and Asian ethnicities. A previously identified risk factor, SNP rs3740030, displayed
different frequencies in the Asian cohorts but risk could not be established. In 15 patients 13 very rare
heterozygous nucleotide substitutions were identified, of which eight led to non-synonymous and four to
synonymous amino acid exchanges and one mapped to the canonical splice site in intron 3. Their impact
on creatine transport was tested in Xenopus laevis oocytes and human HEK293T cells. Four variants
(p.Ser158Pro, p.Gly205Val, p.Pro395Gln and p.Ser453Arg) displayed severe reduction in both model sys-
tems, indicating conserved function. Two of these, p.Gly205Val, and p.Ser453Arg, did not localize to
the oocyte membrane, suggesting possible impacts on protein interactions for transporter processing. In
support, exogenously supplied excess of MCT12’s chaperone CD147 in HEK293T cells led to a partial
recovery of the defective uptake activity from p.Gly205Val and also from mutant p.Pro395Gln, which did
localize to the membrane. Our findings provide first insight in the molecular requirements of creatine
transporter, with particular emphasis on rescuing effects by its chaperone CD147, which can provide
useful pharmacological information for substrate delivery.
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Abstract
Membrane transporters influence biological functions in the ocular lens. Here, we investigate the monocarboxylate
transporter 12 (MCT12), also called creatine transporter 2 (CRT2), which is found in the ocular lens and is involved in cataract.
As the age-related form affects about half of the population world-wide, understanding relevant pathomechanisms is a pre-
requisite for exploring non-invasive treatments. We screened the coding exons of the gene SLC16A12 in 877 patients from
five cohorts, including Caucasian and Asian ethnicities. A previously identified risk factor, SNP rs3740030, displayed different
frequencies in the Asian cohorts but risk could not be established. In 15 patients 13 very rare heterozygous nucleotide substi-
tutions were identified, of which eight led to non-synonymous and four to synonymous amino acid exchanges and one
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mapped to the canonical splice site in intron 3. Their impact on creatine transport was tested in Xenopus laevis oocytes and
human HEK293T cells. Four variants (p.Ser158Pro, p.Gly205Val, p.Pro395Gln and p.Ser453Arg) displayed severe reduction in
both model systems, indicating conserved function. Two of these, p.Gly205Val, and p.Ser453Arg, did not localize to the oocyte
membrane, suggesting possible impacts on protein interactions for transporter processing. In support, exogenously supplied
excess of MCT12’s chaperone CD147 in HEK293T cells led to a partial recovery of the defective uptake activity from
p.Gly205Val and also frommutant p.Pro395Gln, which did localize to the membrane. Our findings provide first insight in the
molecular requirements of creatine transporter, with particular emphasis on rescuing effects by its chaperone CD147, which
can provide useful pharmacological information for substrate delivery.
Introduction
Cataract is a condition of opacities within the ocular lens lead-
ing to visual deficits and eventually complete blindness. Based
on age of onset, one can distinguish between juvenile (congeni-
tal or childhood) cataracts and the very common age-related
cataracts (ARC). The juvenile form represents a small fraction of
all cataracts and often exhibits Mendelian inheritance with over
30 involved genes (1–3). In contrast, the age-related form is con-
sidered a multifactorial disease where environmental and ge-
netic factors influence the development of the disease. Despite
its very high frequency of occurrence worldwide irrespective of
ethnicity and economic conditions, only few genetic factors for
ARC have been identified so far, primarily by genetic association
studies. Among them are the structural protein crystalline al-
pha (CRYAA) (4), the glutathione S transferase (GST) (5,6), DNA
repair enzymes XRCC1, XPD and APE1 (7–9), the epithelial cell re-
ceptor protein tyrosine kinase (EPHA2) (10–12), and the mono-
carboxylate transporter MCT12 (creatine transporter CRT2)
(SLC16A12) (13,14).
To supply the avascular lens with metabolites, membrane
transporters are needed. One such transporter is MCT12
(OMIN 611910), which is 1 of 14 members of the SLC16 mono-
carboxylate transporter family (15). Initially, it was shown to
be associated with cataract by the finding of a premature stop
codon mutation, which segregated in a large family with a
syndromal autosomal dominant juvenile cataract (16).
Consequently, mutations in SLC16A12 were also found to asso-
ciate with age-related cataract (13,14). Like other members of
the MCT family, MCT12 translocates to the plasma membrane
by interacting with the molecular chaperone CD147 (basigin),
encoded by BSG (OMIM 109480) (17–20). CD147 is a ubiquitously
expressed glycoprotein involved in many cellular functions,
such as matrix metalloproteinase induction, inflammation
and tumor invasion (21–25). The interaction between the chap-
erone and its MCT partners was shown to be important for the
maturation process of both, CD147 and monocarboxylate
transporters (26). Additionally, it is suggested that, once at the
membrane, CD147 and MCTs stay together in oligohetero-
dimers to perform their task of substrate transport (19,20). In
the case of MCT12 this substrate is creatine (13), a spatial and
temporal energy buffer usually found in tissues with high en-
ergy demands such as skeletal and cardiac muscle, brain and
retina (27). Suggested roles of creatine in the lens may involve
an energy pathway alternative to oxidative phosphorylation
by rapidly providing and storing excess energy as well as anti-
oxidant activity through its capability to scavenge free radicals
(28) and protection against UV radiation, a risk factor for cata-
ract (29). Consequently, mutations in MCT12 that interfere
with chaperone CD147 interaction or creatine docking and re-
lease could lead to cataract formation. Alternatively, patho-
mechanisms involving aggregation of misfolded proteins as
well as altered response to cellular stress, as has been shown
for a premature stop codon mutation in MCT12 (17), are possi-
bilities. To understand the complexity of MCT12 (CRT2) func-
tion, we screened DNA from patients with ARC and identified
and investigated sequence variants in MCT12 to shed light on
its pathomechanism with emphasis on creatine uptake and
potential rescue via its chaperone CD147.
Results
Mutation screening in the protein-coding region of
SLC16A12
We screened 877 patients who were diagnosed with age-related
cataract (ARC) (Table 1) for sequence variants in the coding
region and canonical splice sites of exons 3 to 8 of SLC16A12
and identified 13 different heterozygous sequence variants in 15
patients (Table 2), yielding approximately a 1: 60 frequency of
affected patients. Only one variant mapped to the canonical
splice site c.200þ 3A>G (IVS3) (patient ID #1), while the others
localized to the coding region. No clustering of variants to a par-
ticular region of the gene was found (Table 2). Five variants
were novel [c.178A>G: p.Ile60Val (patient ID #3), c.200þ 3A>G
(patient ID #1), c.228C>G: p.Phe76Leu (patient ID #4),
c.1184C>A: p.Pro395Gln (patient ID #12), and c.1359T>G:
p.Ser453Arg (Patient ID #15)]. The other eight were very rare in
the European (<0.002) and Asian (<0.0009) Exome Aggregation
Consortium (ExAC) data base (Table 3). Four variants did not
cause a change in amino acid [p.Ala53Ala (patient ID #2),
p.Thr87Thr (patient ID #5), p.Ile178Ile (patient ID #10), and
p.Ala410Ala (patient ID# 14)], while for eight variants a non-
synonymous amino acid change was the consequence of the
nucleotide substitution [p.Ile60Val (patient ID #3), p.Phe76Leu
(patient ID #4), p.Thr136Met (patient IDs #6, 7, 8), p.Ser158Pro
(patient ID #9), p.Gly205Val (patient ID #11), p.Pro395Gln
(patient ID #12), p.Ser406Cys (patient ID #13), and p.Ser453Arg
(patient ID #15)]. We applied algorithms to assess potential
effects on gene expression with primary focus on splicing for
these variants (Supplementary Material, Table S1). For the
c.200þ 3A>G (IVS3) variant a splice donor site is likely
affected and for the four synonymous amino acid changes
altered exonic splicing enhancer (ESE) binding sites were
predicted. Variants leading to non-synonymous amino acid
changes were also predicted to have effects on gene expres-
sion, mostly affecting ESE binding sites and in one case a
weakly activated cryptic donor site. Among the variants lead-
ing to an amino acid exchange, of particular interest is the
novel variant p.Ser453Arg, for which a stronger splice acceptor
site as well as a novel strong cryptic splice donor site were pre-
dicted (Supplementary Material, Fig. S1). Usage of the new do-
nor site is predicted to lead to skipping of exon 7 and the first
70 nucleotides of exon 8, which would result in a premature
termination after 8 amino acids.
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Considering the evolutionary relations, all variants appeared
highly conserved. Together with dramatic changes in amino
acid characteristics (Table 3) the alterations are likely to pose
a negative effect on protein function. Application of five
algorithms (AlignGVGD, SIFT, MutationTaster2, PolyPhen2 and
UMD) aiming to assess pathogenicity yielded varying predic-
tions (Supplementary Material, Table S1); not a single variant
was predicted to be disease causing by all five algorithms. All
but one variant [rs190323395 (c.407C>T; p.Thr136Met)], were
found only once in the patient cohorts. This exception was de-
tected in three patients, all from the Malayan Singapore cohort
(patient IDs #6, 7, 8) (Table 2). The frequency of this variant in
the Asian population is very low (<0.00001) and hence is not
likely to represent a common risk factor for ARC in this ethnic
group. An alternative explanation of genetic relatedness among
the three patients is not necessarily given as the genomic DNA
of one of the three patients carries a distinct SNP rs3740030 al-
lele. Four of the five prediction algorithms suggested a patho-
genic consequence for this variant (Supplementary Material,
Table S1).
Table 2. Rare SLC16A12 sequence variants identified in cataract patients. Patients’ identifiers (ID) were assigned at random. The source and eth-
nicity of the cohorts were from Switzerland (CH), Canada and Singapore. The latter cohort could be specified to the following ethnicities: SINDI
(Indian), SCES (Chinese) or SiMES (Malay). When ethnicity information was not available, it is marked as (na). Variant information included
exon location, cDNA and amino acid (aa) substitution
patient ID source/ethnicity SLC16A12 exon cDNA change aa substitution
1 CH/na 3 c.200þ 3 A>G (IVS3) none
2 Singapore SINDI (Indian) 3 c.159T>C p.Ala53Ala
3 CH/na 3 c.178A>G p.Ile60Val
4 Singapore SCES (Chinese) 4 c.228C>G p.Phe76Leu
5 Singapore SCES (Chinese) 4 c.261G>A p.Thr87Thr
6 Singapore SiMES (Malay) 5 c.407C>T p.Thr136Met
7 Singapore SiMES (Malay) 5 c.407C>T p.Thr136Met
8 Singapore SiMES (Malay) 5 c.407C>T p.Thr136Met
9 CH/na 6 c.472T>C p.Ser158Pro
10 CH/na 6 c.534C>T p.Ile178Ile
11 Singapore SINDI (Indian) 6 c.614G>T p.Gly205Val
12 Singapore SiMES (Malay) 7 c.1184C>A p.Pro395Gln
13 Canada/na 7 c.1217C>G p.Ser406Cys
14 Singapore SiMES (Malay) 7 c.1230G>A p.Ala410Ala
15 CH/na 8 c.1359T>G p.Ser453Arg
Table 3. Frequency of rare variants in population and their effect on MCT12. Change in cDNA and amino acid is related to effects on MCT12 as
change in amino acid characteristics and the closest conserved species. SNP nomenclature is given where applicable; novel variants are indi-
cated by minus (–). Frequencies in European and Asian population are taken from exome aggregation consortium (ExAc) database













c.200þ 3 A>G (IVS3) none – – – – none
c.159T>C p.Ala53Ala rs577369974 0.00000 0.00091 0.00000 none
c.178A>G p.Ile60Val – – – – nonpolar to nonpolar Chicken
c.228C>G p.Phe76Leu – – – – nonpolar to nonpolar Tetraodon
c.261G>A p.Thr87Thr rs761769735 0.00000 0.00000 0.00093 none
c.407C>T p.Thr136Met rs190323395 0.00015 0.00000 0.00000 hydroxyl to nonpolar Baker’s yeast
c.472T>C p.Ser158Pro rs150800688 0.00197 0.00000 0.00000 hydroxyl to nonpolar Frog
c.534C>T p.Ile178Ile rs192441993 0.00000 0.00000 0.00081 none
c.614G>T p.Gly205Val rs778507843 0.00000 0.00006 0.00000 nonpolar to nonpolar Fruitfly
c.1184C>A p.Pro395Gln – – – – nonpolar to amide Fruitfly
c.1217C>G p.Ser406Cys rs145362501 0.00000 0.00018 0.00000 hydroxyl to sulfhydryl Chicken
c.1230G>A p.Ala410Ala rs748432746 0.00000 0.00006 0.00000 none
c.1359T>G p.Ser453Arg – – – – hydroxyl to basic Tetraodon
Table 1. Description of study. Listed are the origin, source and
number of patients
Origin of sample Clinic, cohort/referring clinician No. patients
Canada Hospital for Sick Children/E. Heon 24
Switzerland Hopital ophtalmique Jules-Gonin
Sion/F. Munier
340
Singapore Singapore Malay Eye Study (SiMES) 192
Singapore Singapore Indian Eye Study (SINDI) 192
Singapore Singapore Chinese Eye Study (SCES) 129
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In addition to the very rare variants described above, SNP
rs3740030 occurs at higher frequency in the general population
(European including Finnish: 0.1139; South Asian: 0.0238; East
Asian: 0.2235). In a previous study, we reported evidence that
the minor allele of rs3740030 is a risk factor for ARC, using our
Swiss control population (14). Analysis of these SNP alleles in
the ARC patient samples from Singapore revealed a dramatic
difference in frequency within the three ethnic groups but
based on the frequencies within their respective ethnical popu-
lation the existence of a risk or protective factor was not sup-
ported (P¼ 0.6467 for the Malays; P¼ 0.4237 for the Indian and
P¼ 0.6242 for the Chinese) (Table 4).
Functional characterization of amino acid substitutions
in MCT12
The function of the variants with non-synonymous amino acid
changes was assessed by measuring creatine uptake in the het-
erologous expression system of Xenopus laevis oocytes, where
the identification of creatine as a substrate for MCT12 had been
performed and uptake conditions had been established.
Variants p.Ser158Pro, p.Gly205Val, p.Pro395Gln, p.Ser406Cys,
and p.Ser453Arg showed statistically significantly reduced crea-
tine uptake compared to reference MCT12 (Fig. 1A,
Supplementary Material, Table S2). Experimental conditions for
substrate uptake into frog oocytes require a temperature of 24
C. To address a potential temperature sensitive effect, those
variants with a creatine uptake reduction of 50% or more
(p.Ser158Pro, p.Gly205Val, p.Pro395Gln, and p.Ser453Arg) were
tested at 37 C in human HEK293T cells, a temperature more
physiologically relevant to humans. A highly comparable up-
take profile was observed with around 50% reduction for variant
p.Ser158Pro, 85% for p.Pro395Gln and up to 97% reduction for
p.Gly205Val and p.Ser453Arg (Fig. 1B). Creatine uptake in the lat-
ter two variants was statistically indistinguishable from the
non-injected oocytes (P¼0.0801 and P¼ 0.1407, respectively) and
non-transfected HEK293T cell controls (P¼ 0.2435 and
P¼ 0.1757, respectively). In HEK293T cells, interference from the
natively expressed sodium dependent creatine transporter 1
(CRT1, SLC6A8) has been ruled out by the use of a sodium free
uptake buffer.
To gain better understanding of the underlying reason for
the reduced uptake, we analyzed membrane localization of the
MCT12 mutants after injection into frog oocytes or transfection
of HEK293T cells and compared it to the reference. An antibody
against the C-terminal amino acids (499: 516) of MCT12 was
generated and tested for specificity. Western blots from injected
frog oocyte lysates showed a single strong band of approxi-
mately 37 kD in size, that is not seen in non-injected controls
(Supplementary Material, Fig. S2). The difference to the ex-
pected size of MCT12 (53.4kD) might be due to detergent effects,
a phenomenon not uncommonly observed for membrane pro-
teins (30). Alternatively, or in addition, protein modifications
may also play a role here, as was described for alpha crystallins
(31) or S-nitrosation of MCT1 (32). This verified anti-MCT12 anti-
body was used to investigate MCT12 membrane localization by
immunofluoresence. Oocytes injected with reference or mutant
MCT12 displayed an MCT12 specific signal at the cell membrane
for all variants except for p.Gly205Val and p.Ser453Arg with se-
vere reduction in creatine uptake. The mutation p.Pro395Gln,
which also leads to a strong reduction in creatine uptake, did lo-
calize to oocyte membranes (Fig. 2). As expected, no signal was
detected in non-injected (NI) oocytes. Immunocytochemistry of
transfected HEK293T cells revealed the presence of MCT12 for
all constructs, although no strict membrane localization was
observed (Fig. 2).
Possible functional rescue through exogenous
supplementation of CD147
To assess interactions between MCT12 mutations and the mo-
lecular chaperone we investigated the effect of exogenous hu-
man CD147 on creatine uptake by reference MCT12 and the
respective mutations in frog oocytes and HEK293T cells. It was
shown previously that endogenous X. laevis CD147 is sufficient
to localize MCT12 to the oocyte membrane and facilitate crea-
tine transport (13,33). However, this might not be the case for
the mutations p.Gly205Val and p.Ser453Arg as human and frog
CD147 only share 45% homology. In the frog oocyte system the
addition of human CD147 does not seem to have a statistically
significant effect on either creatine uptake (Supplementary
Material, Fig. S3) or membrane localization (Supplementary
Material, Fig. S4). In the human cell culture system three differ-
ent creatine uptake time points, 1, 5 and 10min, in absence and
presence of exogenous CD147 were tested. As expected, for cells
transfected with reference MCT12 without additional CD147 the
intracellular creatine concentration is rising with increasing in-
cubation time for creatine uptake (Fig. 3A). The addition of exog-
enous CD147 to MCT12 led to statistically significantly reduced
creatine uptake at 5 and 10min of uptake time (P¼ 0.0018 and
P¼ 0.0151 respectively) (Fig. 3A, Supplementary Material, Table
S3). In contrast, overexpression of the molecular chaperone
CD147 significantly improves the uptake of creatine by the vari-
ants p.Ser158Pro, p.Gly205Val and p.Pro395Gln at all tested up-
take time points (Fig. 3B–D, Supplementary Material, Table S3).
Measured values for creatine uptake of variant p.Ser453Arg in
absence or presence of exogenous CD147 were below the limit
of detection (data not shown in graph Fig. 3, but in
Table 4. Risk factor analysis of SNP rs374003o. Patients (cases) and ethnically matching controls for the three tested ethnicities are listed.
Major (T) and minor (G) allele frequency is given including the percent (%) of the minor allele as well as minor allele frequency (MAF). P value
was derived from calculations for odds ratio. Significance level is 0.05
Patients and controls T G total %G MAF p
SiMES (Malay) cases 286 86 372 23.12 0.2312 0.5967
SiMES (Malay) controls 1721 555 2276 24.40 0.2440
SINDI (Indian) cases 378 6 384 1.56 0.0156 0.3222
SINDI (Indian) controls 1759 43 1802 2.39 0.0239
SCES (Chinese) cases 199 55 254 21.65 0.2165 0.5657
SCES (Chinese) controls 1410 355 1765 20.11 0.2011
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Supplementary Material, Table S3). While creatine uptake was
generally increased in the presence of additional CD147, the dif-
ference between absence and presence of CD147 at each time
point was not constant. This difference was visualized in the
line graph (Fig. 3E), The most positive changes upon CD147 ad-
dition could be seen for variant p.Gly205Val (Fig. 3E,
Supplementary Material, Table S3). This rescue effect becomes
statistically significantly greater with increasing creatine uptake
time (for all comparisons P< 1.0E-9). A very similar profile can
be seen for variant p.Pro395Gln, although the total increase of
creatine uptake is not as strong (for all comparisons P< 1.0E-8).
Variant p.Ser158Pro did not show strong sensitivity to uptake
time as can be seen in the almost linear slope of the line graph,
and in the fact that only the difference between 1 and 5min is
statistically significant (P¼ 0.0036) (Fig. 3E, Supplementary
Material, Table S3).
The effects of human CD147 overexpression on the localiza-
tion pattern of MCT12 within HEK293T cells was examined
through double staining with anti-CD147 and anti-MCT12 anti-
body (Fig. 4, Supplementary Material, Fig. S5). Supplementation
of CD147 seems to improve membrane localization in cells
transfected with reference or mutant constructs. As expected,
some endogenous CD147 expression was detected by the stain-
ing, but no endogenous MCT12 expression is visible.
Discussion
The collection of very rare variants reported here did not con-
tain deletions, insertions or frameshift effects. Little less than
half of them (40%) had not been reported previously in sequence
variant databases. All but one of the variants maps to the coding
region, suggesting that functional alteration of the protein with
possible consequences in localization, protein-protein interac-
tions or substrate transport are impacted and may ultimately
lead to the disease. Certainly, screening the coding regions pre-
sents a bias towards these kinds of variants. In addition to caus-
ing potential disruption of transporter function, some of the
coding region mutations may also lead to exonic splicing en-
hancer (ESE) sequence alterations, and are thereby predicted to
affect gene expression (34). An estimation of the extent of ESE
effect has been reported previously (35) where a combined
approach of bioinformatics and experimental evidence showed
that about 25% of coding region mutations that cause human
disease are likely due to exon skipping involving both, exonic
splicing enhancers (ESE) and silencers (ESI). In our collection,
three of the four synonymous coding region variants are pre-
dicted to alter splice sites with pathogenic consequences.
Among the non-synonymous alterations that we found, all are
predicted to alter splice sites but their validity needs to be
tested. A highly probable case may present the mutation
c.1359T>G, p.Ser453Arg, where a predicted frame shift with
premature termination may have important consequences on
function within the human lens. For the three non-
synonymous mutations that did not display deficiencies in cre-
atine uptake in the Xenopus laevis oocyte system predicted splice
defects could be the mechanism of pathogenicity. Similarly,
mutation c.1217C>G showed statistically significant reduction
of creatine uptake in the oocyte system, but not below the 50%
level, the predicted gain of an ESE site may contribute to
pathogenicity.
The impact of sequence variants on protein function was es-
timated with the help of five prediction algorithms (AlignGVGD,
SIFT, PolyPhen2, MutationTaster2 and UMD), all based on vari-
ous features of the protein, like the degree of sequence homol-
ogy, 3D-folding, evolutionary conservation, and functional
homologies. The validity of such predictions will come from
functional assays. In our cases, half of the non-synonymous
amino acid variants resulted in more than 50% reduction of cre-
atine uptake. A most striking contrast was noticed for
p.Ser453Arg, which is evolutionary highly conserved, and al-
though only two of the five algorithms predicted pathogenicity,
function is completely abolished in both model systems. A com-
bination of the potential splice defect discussed above with the
observed defect in substrate uptake at the protein level and lack
of membrane localization seems a likely cause for the pathoge-
nicity. Not surprisingly, addition of CD147 did not rescue this
defect. Unfortunately, patient‘s material was not available for
further testing.
Given that for the here reported mutations the changes in
biochemical properties of the substituted amino acid are strong
and the affected amino acids display evolutionary conservation,
it is surprising that not a single mutation was predicted
Figure 1. Functional analysis of sequence variants in MCT12. Creatine uptake was measured in (A) Xenopus laevis frog oocytes at 24 C and in (B) HEK293T cells at 37 C
after incubation with creatine for 10min. Uptake is expressed in percent relative to the reference sequence (Ref). Non-injected oocytes (NI) and non-transfected (ctr)
HEK293T cells show endogenous background. In oocytes, the eight identified non-synonymous cataract associated variants were tested. Statistical significance was de-
termined using unpaired, two-tailed t-tests with Welch‘s correction in comparison to the reference (Ref) values (*P0.05, **P0.01). Error bars reflect standard error of
the mean (SEM). Mean values contain 5 to 16 different oocytes from at least 3 different uptake experiments with oocytes from different frogs. HEK293T cell uptake as-
says were performed with quadruple repeats and each condition was tested three times. In the frog oocytes sequence variants with dark bars indicate a reduction of
50% or more creatine uptake relative to Ref. These mutations were tested in HEK293T cells.
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pathogenic by all programs. Such contrasting results of predic-
tion and experimental evidence have been previously reported
and need consideration in diagnostics from NGS data (36,37).
p.Gly205Val is another variant that did not localize to the oo-
cyte membrane. The substitution of glycine with valine could
alter the structure of the respective resident transmembrane
domains, either directly or indirectly by possibly preventing re-
quired or enabling novel molecular interactions, for example
with the chaperone CD147. When glycine, which has rich con-
formational flexibility, is substituted by the larger amino acid
valine, disruption of the secondary structure of the protein is
likely. Alternatively, a process known as unfolded protein re-
sponse (UPR) could be initiated by the mutation as has been
shown for another mutation in SLC16A12 (17) and also for muta-
tions in collagen IVa, leading to cataract (38). p.Ser158Pro,
p.Pro395Gln and p.Ser406Cys are mutations in which creatine
uptake was reduced, but the protein MCT12 can be found at the
oocyte membrane. A partial translocation defect cannot be ex-
cluded though, as our membrane localization assay was not
quantitative. Substitution of the serine, and thereby loss of a po-
tential phosphorylation site, may contribute to the defective up-
take, as was shown for the glutamine transporter SN1
(SLC38A3), where phosphorylation of an N-terminal serine by
protein kinases a and c is essential for membrane trafficking
(39). Alternatively, the serine to proline or cysteine substitution
could affect creatine binding, rendering transport less efficient.
Proline residues generally tend to be non-reactive but allow
conformational changes that show flexible behavior in different
physiological states (40). Substitution with the polar glutamine
in p.Pro395Gln, which tends to interact with other polar amino
acids of adjacent proteins, may lead to novel protein-protein in-
teractions. Such novel interactions have been described be-
tween the intracellular protein carbonic anhydrase II and MCT1
or MCT4 monocarboxylate transporters, leading in those exam-
ples to increased function (41).
In our initial choice of experimental model, the heterologous
Xenopus laevis oocyte system, temperature sensitive effects
leading to misprocessing have been reported for mutations in
the membrane protein HERC channel (42) and the most fre-
quently occurring mutation (DF508) in the cystic fibrosis gene
CFTR, which functions better at lower temperatures (43). To as-
sess whether such temperature sensitive responses also ac-
count for the MCT12 mutations analyzed here, all constructs
were also tested in human cells. As the uptake results were
comparable in both systems, temperature sensitive effects on
the variants seemed unlikely. In contrast, for the interaction be-
tween MCT12 and the chaperone CD147 a species-specific effect
becomes apparent, as the addition of CD147 only yielded res-
cued uptake in human cells and not in frog oocytes. A similar
situation has been reported in the case of chaperone Hsp70 and
the DF508 mutation in CFTR (44), and effects such as these could
be, but are not necessarily, related to temperature.
Interestingly, sensitivity to the time of uptake in dependence of
chaperone CD147 supply became quite apparent; while the ref-
erence construct displayed reduced uptake over time from 1 to
10min, the mutants conversely improve substrate uptake. A
possible explanation might involve the bidirectional nature of
creatine transport by MCT12 (13). Further, correct stabilization
of MCT12, facilitated by CD147, could be a requirement for crea-
tine transport. This stabilization may have a mutant-specific ef-
fect. Overexpression of CD147 may also explain these
observations. Using cells where the endogenous CD147 is si-
lenced may shed light on this possibility. Furthermore, we can-
not exclude whether additional chaperone molecules other
than CD147 might be necessary to support correct function of
MCT12. Embigin, a close homolog of CD147, is one possible can-
didate as it is the chaperone for MCT2 (19). In support MCT1,
whose general chaperone is CD147, was found to also interact
with embigin in rat erythrocytes (45). It should be noted that al-
though we were able to test function via substrate uptake, we
cannot exclude effects on substrate efflux or other, possibly
more subtle physiological conditions. The variants for which no
uptake deficiency was found (p.Ile60Val, p.Phe76Leu and
p.Thr136Met) could belong into that group due to inertia of the
specific amino acid exchange or the location of the affected
amino acid within the transporter that is unrelated to substrate
uptake. We cannot completely rule out that these variants may
be unrelated to ARC as their low frequency does not allow for
genetic association tests in populations.
One of our aims was to assess how frequent sequence vari-
ants in SCL16A12 can be found in patients with ARC. With an
approximately 1 in 60 frequency, SLC16A12 is next to EPHA2 (10)
among the most frequently affected genes. Combination of this
Figure 2. Localization of MCT12 and variants. Immunofluorescence of injected
X. laevis oocytes (left) or transfected HEK293T cells (right) with antibody against
the C-ter of MCT12 (red in oocytes, green in HEK293T) and DAPI (blue, only in
HEK293T). Reference sequence and representative variants p.G205V and p.P395Q
are shown. As controls non-injected oocytes and non-transfected cells are
shown as well as a secondary antibody control of the reference sequence.
Arrows point to membrane staining.
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frequency with the presence of MCT12 transporter and its chap-
erone CD147 in human ocular lens (Supplementary Material,
Fig. S6) may justify searches for non-invasive treatment meth-
ods, alternatively to the commonly performed surgery. One ap-
proach could employ supplements of creatine, an approach that
was successful in mice with X-linked SLC6A8 (CRT1) mutations
(46). As creatine supplements in humans have been approved
by the Food and Drug Administration (FDA) in the USA, a first
hurdle has been taken for investigations in humans. Another
approach addresses the effects of molecular chaperones. Here,
we could demonstrate a positive response to cataract-
associated mutation-induced creatine uptake deficiencies by
supplying exogenous CD147 in mammalian cell culture. The
mechanism of the partial rescue of mutations p.Ser158Pro,
p.Gly205Val, and p.Pro395Gln is not yet understood. It is inter-
esting that both, mutations leading to membrane localization or
not, can be rescued. Likely, the mutations map to sites within
MCT12 that are important for interaction with CD147 causing
sub-optimal conditions for proper trafficking. Over-abundance
of CD147 appears to overcome this problem. The here reported
partial rescue gives encouraging signals for further studies of
optimization. In previous studies, effects of chaperone treat-
ments on different diseases provided promising results. It was
shown that overexpression of chaperone Hsp70 led to improved
interaction with the DF508 mutant in the cystic fibrosis gene
CFTR (44). In another example, application of small corrector
molecules (VX-809) could rescue processing mutants in the
Stargardt eye disease ABCA4 protein (47). A note of caution
Figure 3. Influence of CD147 on creatine uptake in HEK293T cells. Uptake of creatine in pmol/mg protein is shown in bar graphs for the reference sequence (Ref) (A) and
variants p.S158P (B), p.G205V (C) as well as p.P395Q (D) in the absence (light bar) and presence (dark bar) of exogenous CD147 during 1, 5 or 10min of uptake. Unpaired,
two-tailed t-test with Welch‘s correction was applied. CD147 overexpression leads to a statistically significant increase in creatine uptake for all three shown mutants
at all three time points and a statistically significant decrease for the reference at 5 and 10min. The difference between without and with CD147 is displayed in the line
graph (E). Error bars indicate standard error of the mean. Numerical data are given in Supplementary Material, Table S4. Same experiments were performed for variant
p.S453R but as all data points were below the limit of quantification (Supplementary Material, Table S4), no bar or line graph display is given.
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is based on the fact that chaperones usually play several impor-
tant roles in cellular processes and hence alteration of its con-
centration may lead to unwanted responses.
Taken together, our screen for pathogenic variants in
SLC16A12 yielded a collection of sequence variants of which
about half displayed functional deficiency with respect to sub-
strate uptake. This was observed in two evolutionary and exper-
imentally rather distant models: frog oocytes and human cells.
The functional deficiency could be partially rescued in the hu-
man model by addition of chaperone CD147. Further investiga-
tions in potential non-invasive treatments are encouraged.
Materials and Methods
Patients with cataracts
Patients diagnosed with age-related cataract were (i) from
Switzerland (340 patients diagnosed by Dr. F. Munier), (ii) from
Canada (24 patients diagnosed by Dr. E. Heon) and (iii) from
Singapore (513 subjects with age-related cataracts from three
different ethnic backgrounds; 192 Singaporean Malays (48–50),
192 Singaporean Indian (51,52) and 129 Singaporean Chinese
(52) from the Singapore Epidemiology of Eye Diseases Study (53)
(Table 1). All patients from Singapore had mostly severe nuclear
age-related cataract with a small subset (approximately 20%)
that had additional cortical and/or additional subcapsular cata-
ract. Participation at the different sites was approved by the re-
spective ethics regulatory bodies and all patients gave written
informed consent. Experiments respected the principles ex-
pressed in the Declaration of Helsinki.
SLC16A12 DNA sequence analysis
Genomic DNA from venous blood was amplified using primers
for coding exons 3 to 8 of SLC16A12 gene (Supplementary
Material, Table S4) (Entrez ID 387700, NM_213606.3). PCR amplifi-
cation and Sanger sequencing were performed as described
(14,16). Initially, 50ng genomic DNA was amplified in a 25 ll re-
action volume. Tests with 1-5ng genomic DNA in 10 ll reaction
volume yielded equivalent results and hence, the latter condi-
tions were chosen for most of the PCR reactions.
Electropherograms were evaluated using SeqScape (ABI) soft-
ware. DNA samples showing variants were subjected to a sec-
ond PCR and sequencing reaction. Variants were annotated
using Alamut-Visual (Interactive Biosoftware). For missense
mutations, five common algorithms (SIFT (54), MutationTaster2
(55), Align GVGD (56,57) PolyPhen2 (58) and UMD (59)) were ap-
plied to predict pathogenicity. Genotype data for SNP rs3740030
from the control groups from Singapore were provided by the
Singapore Eye Research Institute.
Cloning and in vitro transcription
SLC16A12 reference (ENST00000341233; protein Q6ZSM3; 486
amino acids) cDNA clone in vector KSM for Xenopus laevis oocyte
injections has been described (13). This clone was used for site
directed mutagenesis (60) to generate constructs with the cata-
ract associated sequence variants (Supplementary Material,
Table S4). To eliminate the template DNA, amplification prod-
ucts were digested with methylation sensitive restriction en-
zyme DpnI (Fermentas). Clones were verified by Sanger DNA
sequencing. DNA of confirmed plasmids were linearized using
NotI, BstXI or SacII, followed by in vitro transcription of 1 lg line-
arized DNA using the MEGAscript T3 High Yield Transcription
kit (AMbion), including G(5’)ppp(5’)G RNA Cap structure analog
(New England Biolabs) in a volume ration of 1: 3 with GTP.
Quality and quantity of RNA were determined using the Agilent
RNA 6000 Nano kit (Agilent). All nucleotide primers were syn-
thesized at Microsynth, Balgach, Switzerland.
For transfection of HEK293T (GE healthcare Bio-Sciences AB)
cells, the SLC16A12 reference and sequence variants in the
BlueScript derived vector KSM (see above) were cloned into the
bicistronic vector pIRES2-EGFP (Adgene). Both plasmids were
linearized using restriction enzyme EcoRI and XhoI
(ThermoScientific) and resulting fragments were gel extracted
with the NucleoSpinVR Gel and PCR Clean Up kit (Macherey-
Nagel). The pIRES-EGFP backbone and cDNA insert were ligated
with T4 DNA ligase (Promega). Plasmid identity was confirmed
by Sanger Sequencing. Clones containing cRNA of BSG (CD147;
ENST00000333511; protein P35613; 385 amino acids) for Xenopus
laevis oocyte injections as well as cDNA of BSG in the pIRES-
EGFP vector for transfection of HEK293T cell culture were pre-
pared as described above for SLC16A12.
Creatine uptake assay
Xenopus laevis oocytes, Injection procedure and uptake assays
were performed as previously reported (13). For each MCT12
construct at least 10 oocytes from a given frog were injected
with 25ng/50 nl of SLC16A12 RNA. Experiments were repeated 3
to 5 times with eggs from different frogs. For the constructs that
Figure 4. Localization of MCT12 and variants with and without exogenous CD147.
Immunofluoresence of transfected HEK293T cells with antibody against MCT12
(green), CD147 (red) and DAPI (blue). Shown are cells transfected with reference
sequence as well as variants p.G205V and p.P395Q without (left) and with (right)
addition of exogenous CD147. Non-transfected cells were used as control.
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showed reduced uptakes a new in vitro transcription reaction
was performed for another set of uptake experiments. Creatine
uptake was calculated relative to uptake in oocytes injected
with reference MCT12.
HEK cell culture, HEK293T cells were cultured in DMEM (Gibco
by Sigma Life Science) [supplied with 10% FCS (Eurobio) and 1%
pen/strep (Corning)] according to standard protocols. Uptake as-
says were carried out in 12-well plates. Cells were transfected
using 1.2 lg of DNA and 3.6 lg PEI (polyethylenimine, Sigma)
transfection agent. 48h after transfection cells were washed in
sodium free wash buffer (150mM Cholin-Cloride, 10mM HEPES
pH7.4, 1mM CaCl2 2H2O, 5mM KCl, 1mM MgCl2 6H2O, 10mM
Glucose, pH7.4) and kept for 5min at 37 C in the second wash.
Per well 300 ll uptake solution (sodium free wash buffer sup-
plied with 50 lM creatine hydrate and 0.1 lCi/ml 14C-creatine
(Hartmann Analytics, Braunschweig, Germany) was added and
uptake was allowed for 1, 5 or 10min at 37 C. Cells were washed
three times with ice cold wash buffer and lysed in 1% Triton X-
100 (Roth) for 30min. Background measurements were taken
from the third wash. Radioactivity was measured using
Emulsifier-SafeTM scintillation cocktail (PerkinElmer) and a
Packard Tri-Carb liquid scintillation analyzer. Protein concen-
tration of lysed cells was determined using the Pierce BCA
Protein Assay (Thermo Fisher Scientific). From the obtained
CPM (counts per minute) measurements uptake values were
calculated in pmol creatine per mg of total protein. All uptakes
were performed thrice and each uptake was carried out in qua-
druplicate repeats for every tested construct. Tests in HEK293T
cells were performed in the absence and presence of exogenous
CD147. The ratio of CD147 and MCT12 cDNA constructs for
transfection was 1: 4. Statistical analysis through unpaired t-
test with Welch‘s correction (a¼ 0.05) and graphical displays
were done in Prism 6 (Graphpad).
Immunofluorescence
Xenopus laevis oocytes, Five to ten oocytes per condition were
prepared for cryosectioning as described (13) and sectioned at
10 lm using a cryomicrotome (Leica). Between steps sections
were washed three times in PBS for 5min. Sections were
blocked for 1h at room temperature in PBS containing 0.05%
Triton-X 100 (PBST) and 2% BSA (Sigma). A primary polyclonal,
affinity-purified, antibody against the C-terminal region (499:
516, nomenclature based on NP_998771.3 the long isoform of
MCT12) of the human MCT12 was produced in rabbits (Thermo
Fisher Scientific). Cryosections were incubated with primary
anti-MCT12 antibodies diluted in PBST (1: 250) for 1h at room
temperature. Secondary goat anti-rabbit IgG Alexa FluorVC 488 or
568 antibody (Thermo Fisher Scientific) (1: 400 dilution in PBST)
was applied for 1h at room temperature. All slides were
mounted using Fluoromount (Sigma) and kept at 4 C. Images
were taken with the EVOSVC FL microscope and processed with
Photoshop CC (Adobe).
HEK cell culture, HEK293T cells were plated on Poly-L-Lysine
(Sigma) treated 22 22 mm cover slips in 6-well plates. 48h after
transfection, cells were fixed in 4% PFA for 20min, permeabi-
lized with 0.2% Triton X-100 for 5min and blocked in 5mg/ml
BSA in PBS for 30min at room temperature. Between steps cells
were washed three times in PBS. Primary antibodies against
MCT12 (499: 516, Thermo Fisher Scientific) and CD147 (Ancell)
were diluted to 1: 200 and 1: 400 respectively, in PBS with BSA.
Cells were re-blocked for 30min. Secondary Alexa FluorVC 488
goat anti-rabbit at 1: 400 and Alexa FluorVC 568 goat anti-mouse
at 1: 800 dilutions (both Thermo Fisher Scientific) were applied
for 45min at 37 C. Cover slips were mounted using
Fluoromount GVR with DAPI (SouthernBiotech) and kept in the
dark at 4 C until microscopy with the EVOS FL Auto Cell
Imaging System. Oocyte images were taken at 20x magnifica-
tion; HEK293T cells at 60x magnification. Representative images
were processed using Adobe Photoshop CC and may have been
digitally magnified.
Human lens. A human lens from a cornea donor without obvi-
ous cataract provided by The University Hospital of Bern was
frozen in liquid nitrogen and embedded in Tissue Tek (O.C.T.
compound, Sakura Finetek, NL) medium without prior fixation
on dry ice and sectioned at 8 lm using a cryomicrotome. The
slides were stored at 80 C. Cryosections were dried for 2min
at room temperature and fixed in 4% PFA for 10min. Between
steps, sections were washed three times in PBS for 5min unless
otherwise stated. The sections were blocked and treated with
2% BSA and 0.05% Triton-X in PBS. Primary antibody against
MCT12 (1: 250, Thermo Fisher Scientific) and CD147 (1: 500, Sino
Biological) were applied to sections for 1h at room temperature.
Cryosections were incubated with secondary antibody Alexa
FluorVR 488 or 568 goat anti-rabbit at 1: 500 or 1: 400 dilution in
blocking solution for 45min in the dark. The slides were
mounted using Fluoromount GVR with DAPI and analysed with
the EVOS FL Auto Cell Imaging System. Representative images
were processed using Adobe Photoshop CC.
MCT12 antibodies and western blots
72h post-injection cell extracts from 5 to 10 Xenopus laevis oo-
cytes were prepared by the addition of 20 ml cold lysis solution
(250mM sucrose, 0.5mM EDTA, 5mM Tris base and freshly pre-
pared protease inhibitors: PMSF (phenylmethylsulphonyl fluo-
ride) 200 lg/ml and PIC (protease inhibitor cocktail) 1mg/ml (all
chemicals from Sigma-Aldrich)). The lysed oocytes were passed
10 times through a 25G needle to homogenize the cells, fol-
lowed by centrifugation at 100 g at 4 C for 10min. Protein con-
centration was determined using PierceTM BCA protein assay kit
(Thermo Fisher Scientific). Gel electrophoresis of 30 mg protein
extract and molecular weight marker (Precision Plus Protein
Dual Color Standards; BioRad) through 10% resolving acrylam-
ide gel was performed followed by transfer to PVDF membrane
using the Semi-Dry Transfer Cell (BioRad). Transfer efficiency
was evaluated with Ponceau S (Sigma Aldrich). After blocking
membrane overnight in 5% milk-TBST, hMCT12 primary anti-
body (1: 500 in blocking solution) was applied for 2h at room
temperature under constant rotation. Following washes, the
secondary antibody (ECLTM anti-rabbit IgG HRP secondary anti-
body) (GE healthcare UK limited) was added in a 1: 10000 dilu-
tion. Membranes were developed using the Western Lightning
Plus-ECLTM detection kit (PerkinElmer) according to manufac-
ture’s specifications and visualized with the Bio-Rad Imager
(ChemiDoc XRSþwith Image Lab Software).
Web sites for sequence information and prediction
programs
Alamut Visual vs2.7.2, a mutation analysis software (http://
www.interactive-biosoftware.com/alamut-visual/). Within Alamut,
programs to predict splice defects (Splice Site Finder-like,
MaxEntScan, NNSPLICE, GeneSplicer, Human Splicing Finder as
well as ESE Predictions with ESEfinder and RESCUE-ESE) have been
used. Predictions for pathogenicity: Polyphen2 (http://genetics.
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bwh.harvard.edu/pph2/), SIFT (http://sift.bii.a-star.edu.sg/),
MutationTaster2 (http://www.mutationtaster.org/), Align GVGD
(http://agvgd.hci.utah.edu/agvgd_input.php), umd-predictor http://
umd-predictor.eu/ Collection of variants: http://exac.broadinstitute.
org/, https://www.ncbi.nlm.nih.gov/snp/, http://cancer.sanger.ac.uk/
cosmic DNA and protein sequence information: Genecards http://
www.genecards.org/and NCBI http://www.ncbi.nlm.nih.gov/and
UniProtKB http://www.uniprot.org/uniprot Statistics: http://vassar
stats.net/tu.html for odds ratio calculations and GraphPad Prism 6
for uptake experiments. All web sites have been accessed last
between February and June 2017.
Supplementary Material
Supplementary Material is available at HMG online.
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